
    
      An open-label, randomized, multi-center, comparative parallel study to evaluate prevention
      effect of combination therapy of Everolimus and low-dose Tacrolimus in comparison with
      standard-dose Tacrolimus therapy with Mycophenolic acid on the New Onset Diabetes Mellitus
      after transplantation in the renal allograft recipients: PROTECT study
    
  